Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca G Bagley

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Research|May 20, 2016
Commentary on Folkman: "Tumor Angiogenesis Factor"Rebecca G Bagley
Biomarkers in Medicine|May 19, 2010
Endosialin: from vascular target to biomarker for human sarcomasRebecca G Bagley
Cancer Research|November 4, 2005
Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancyRebecca G Bagley, William Weber, Cecile Rouleau, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2011
Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cellsRebecca G Bagley, Leslie Kurtzberg, Cecile Rouleau, et al.
Annals of Saudi Medicine|March 23, 2011
Characteristics of human Ewing/PNET sarcoma modelsBeverly A Teicher, Rebecca G Bagley, Cecile Rouleau, et al.
International Journal of Oncology|November 15, 2011
Human choriocarcinomas: placental growth factor-dependent preclinical tumor modelsRebecca G Bagley, Yi Ren, Leslie Kurtzberg, et al.
Journal of Cellular and Molecular Medicine|July 16, 2015
JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in miceFranck Debeurme, Catherine Lacout, Claudine Moratal, et al.
International Journal of Oncology|February 13, 2009
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markersRebecca G Bagley, William Weber, Cecile Rouleau, et al.
Microvascular Research|April 21, 2006
Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapyRebecca G Bagley, Cecile Rouleau, Sharon D Morgenbesser, et al.
Molecular Cancer Therapeutics|April 2, 2014
Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancerMarielle Chiron, Rebecca G Bagley, Jack Pollard, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Research|May 20, 2016
Commentary on Folkman: "Tumor Angiogenesis Factor"Rebecca G Bagley
Biomarkers in Medicine|May 19, 2010
Endosialin: from vascular target to biomarker for human sarcomasRebecca G Bagley
Cancer Research|November 4, 2005
Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancyRebecca G Bagley, William Weber, Cecile Rouleau, et al.
Cancer Chemotherapy and Pharmacology|April 29, 2011
Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cellsRebecca G Bagley, Leslie Kurtzberg, Cecile Rouleau, et al.
Annals of Saudi Medicine|March 23, 2011
Characteristics of human Ewing/PNET sarcoma modelsBeverly A Teicher, Rebecca G Bagley, Cecile Rouleau, et al.
International Journal of Oncology|November 15, 2011
Human choriocarcinomas: placental growth factor-dependent preclinical tumor modelsRebecca G Bagley, Yi Ren, Leslie Kurtzberg, et al.
Journal of Cellular and Molecular Medicine|July 16, 2015
JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in miceFranck Debeurme, Catherine Lacout, Claudine Moratal, et al.
International Journal of Oncology|February 13, 2009
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markersRebecca G Bagley, William Weber, Cecile Rouleau, et al.
Microvascular Research|April 21, 2006
Pericytes from human non-small cell lung carcinomas: an attractive target for anti-angiogenic therapyRebecca G Bagley, Cecile Rouleau, Sharon D Morgenbesser, et al.
Molecular Cancer Therapeutics|April 2, 2014
Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancerMarielle Chiron, Rebecca G Bagley, Jack Pollard, et al.
Pageof 3